Table 4.
Serum hormone comparison among each group ($bar{x}$ ± s)
| Group | n | FSH (IU/L) | LH (ng/mL) | E2 (ng/L) | AMH (ng/mL) | VEGF (ng/L) | BMP-7 (pg/mL) |
|---|---|---|---|---|---|---|---|
| Blank | 10 | 9.26±2.36 | 2.18±0.29 | 65.39±9.74b | 14.98±3.12 | 183.48±29.26 | 1202.88±139.00 |
| Model | 10 | 11.41±2.39a | 2.38±0.77 | 56.32±10.91 | 14.09±2.49 | 180.36±48.23 | 1078.86±213.40 |
| BCD | 10 | 9.89±1.35 | 2.01±0.38 | 64.13±10.72c | 16.95±3.51d | 228.24±48.90e | 1311.59±230.36f |
| EV | 10 | 10.11±1.45 | 2.21±0.60 | 57.99±9.06 | 15.56±3.16 | 163.64±39.58 | 1180.40±216.47 |
Notes: blank group: equal amount of normal saline, 14 d; model group: equal amount of normal saline, 14 d; BCD group: Bushen Culuan decoction, 18.35 g·kg-1·d-1, 14 d; EV group: estradiol valerate intervening group, 0.15 mg·kg-1·d-1, 14 d. FSH: follicle-stimulating hormone; LH: luteinizing hormone; E2: Estradiol2; AMH: anti-Müllerian hormone; VEGF: vascular endothelial growth factor; BMP-7: bone morphogenetic protein-7. aP < 0.05, compared with the other 3 groups; bP < 0.05, compared with model group and EV group; cP < 0.05, compared with model group; dP < 0.05, compared with blank group and model group; eP < 0.05; compared with the other 3 groups; fP < 0.05, compared with model group.